Table 1.
FSE change | ||||||
---|---|---|---|---|---|---|
Participants | Randomized group | Points per year | 95% CI | P value for time × treatment interaction | P value for time × age group interaction | |
Model 1a | All | Intensive | .11 | (.05 to .17) | .95 | NA |
Standard | .11 | (.05 to .17) | ||||
<75 y | Intensive | .01 | (−.06 to .08) | .55 | <.0001 | |
Standard | .05 | (−.02 to .12) | ||||
≥75 y | Intensive | .34 | (.24 to .45) | |||
Standard | .25 | (.14 to .36) | ||||
Model 2a | All | Intensive | .12 | (.06 to .18) | .71 | NA |
Standard | .11 | (.05 to .17) | ||||
<75 y | Intensive | .03 | (−.05 to .10) | .47 | <.0001 | |
Standard | .05 | (−.02 to .12) | ||||
≥75 y | Intensive | .35 | (.24 to .46) | |||
Standard | .26 | (.15 to .37) |
Abbreviations: CI, confidence interval; FSE, falls self-efficacy score; NA, not applicable.
Model 1 adjusted only for treatment and time; model 2 adjusted for treatment, time, age > 75 years, sex, black race, Hispanic ethnicity, cardiovascular disease history, chronic kidney disease status, systolic blood pressure tertile, Veterans RAND 12 Item Health Survey physical and mental scores, Patient Health Questionnaire-9 score, number of chronic diseases, body mass index, living with others, and frailty status.